Mixed lineage leukemia 1 (MLL1) is identified as a significant histone H3 lysine 4 methyltransferase and acts as a novel regulator of DDR, promoting apoptosis in cisplatin-induced renal proximal tubular cells and AKI. This evidence concerns the gene KMT2A and acute kidney injury.